Developing AI based genomics software for seed & food companies.
NRGene Techno is no longer being judged mainly as a software company. It is now an early-stage commercialization story with a real revenue jump and a profitable second half, but one that still depends on a small customer base, milestone-driven cash timing, and an equity base tha…
NRGene Techno's BSF line has moved in 2026 from pure validation into Commercial Validation, but it is still too early to call it a full commercial engine because the launch rests on first orders, a facility that has only just begun operating, and external funding that is still c…
The Above Food deal proves NRGene Techno can recognize revenue, but it has not yet proved the same quality of cash conversion because a meaningful part of the consideration sits in shares, milestones, and royalties.
